Perspective Therapeutics, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CATX research report →
Companywww.perspectivetherapeutics.com
Perspective Therapeutics, Inc. , together with its subsidiaries, develops, manufactures, sells, and markets isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and internationally. The company offers CS-1 Cesium-131 brachytherapy seeds for the treatment of prostate, brain, lung, head and neck, gynecological, pelvic/abdominal, and colorectal cancers.
- CEO
- Johan Spoor
- IPO
- 2005
- Employees
- 138
- HQ
- Seattle, WA, US
Price Chart
Valuation
- Market Cap
- $291.23M
- P/E
- -3.51
- P/S
- 506.49
- P/B
- 1.12
- EV/EBITDA
- -2.17
- Div Yield
- 0.00%
Profitability
- Gross Margin
- -358.09%
- Op Margin
- -20871.83%
- Net Margin
- -19327.48%
- ROE
- -41.84%
- ROIC
- -31.33%
Growth & Income
- Revenue
- $0 · 0.00%
- Net Income
- $-103,121,000 · -30.07%
- EPS
- $-1.40 · -13.82%
- Op Income
- $-113,564,000
- FCF YoY
- -30.98%
Performance & Tape
- 52W High
- $6.16
- 52W Low
- $1.96
- 50D MA
- $4.29
- 200D MA
- $3.62
- Beta
- 1.76
- Avg Volume
- 1.47M
Get TickerSpark's AI analysis on CATX
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Mar 2, 26 | Martinez Maria E | other | 50,000 |
| Mar 2, 26 | Morich Frank | other | 50,000 |
| Mar 2, 26 | Williamson Robert F III | other | 50,000 |
| Mar 2, 26 | HENSON HEIDI | other | 50,000 |
| Mar 2, 26 | Woods Lori A | other | 50,000 |
| Mar 2, 26 | Spoor Johan M. | other | 735,000 |
| Mar 2, 26 | Hunt Jonathan Robert | other | 90,000 |
| Mar 2, 26 | Puhlmann Markus | other | 150,000 |
| Nov 13, 25 | Hunt Jonathan Robert | buy | 11,000 |
| Nov 12, 25 | Williamson Robert F III | buy | 9,498 |
Our CATX Coverage
We haven't published any research on CATX yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate CATX Report →